• Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population 

      Cyprian, Farhan S.; Suleman, Muhammad; Abdelhafez, Ibrahim; Doudin, Asmma; Masud Danjuma, Ibn Mohammed; ... more authors ( Frontiers Media S.A. , 2021 , Article)
      Coronavirus disease-2019 (COVID-19) was declared as a pandemic by WHO in March 2020. SARS-CoV-2 causes a wide range of illness from asymptomatic to life-threatening. There is an essential need to identify biomarkers to ...
    • COVID-19-associated hypertriglyceridemia and impact of treatment 

      Kaddoura, Rasha; Mohamed Ibrahim, Mohamed Izham; Al-Amri, Maha; Prabhakaran Nair, Arun; Alharafsheh, Ahmad; ... more authors ( Frontiers Media SA , 2024 , Article)
      Background: Coronavirus disease 2019 (COVID-19) associated hypertriglyceridemia was observed among patients admitted to intensive care units (ICU) in Qatar. This study aimed to describe COVID-19-associated-hypertriglyceridemia ...
    • Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial 

      Elmekaty, Eman Zeyad I.; Maklad, Aya; Abouelhassan, Rawan; Munir, Waqar; Ibrahim, Mohamed Izham Mohamed; ... more authors ( Frontiers Media S.A. , 2023 , Article)
      Background: The global COVID-19 pandemic led to substantial clinical and economic outcomes with catastrophic consequences. While the majority of cases has mild to moderate disease, minority of patients progress into severe ...
    • Novel polymethoxylated chalcones as potential compounds against kras-mutant colorectal cancers 

      Mahmoud, Alaa; Elkhalifa, Dana; Alali, Feras; Al Moustafa, Ala-Eddin; Khalil, Ashraf ( Bentham Science Publishers , 2020 , Article)
      Background/Objective: KRAS-mutant colorectal cancers (CRC) are tumors that are associated with poor prognosis. However, no effective treatments are available to target them. Therefore, we designed and synthesized novel ...